Changes to Pregnancy and Lactation Risk Labeling for Prescription Drugs

American College of Obstetricians and Gynecologists (ACOG), 2007 Andrade, 2004, Prescription drug use in pregnancy, American Journal of Obstetrics & Gynecology, 191, 398, 10.1016/j.ajog.2004.04.025 Botting, 2002, The history of thalidomide, Drug News and Perspectives, 15, 604, 10.1358/dnp.2002.15.9.840066 Doering, 2002, Review of pregnancy labeling of prescription drugs: Is the current system adequate to inform of risks?, American Journal of Obstetrics & Gynecology, 187, 333, 10.1067/mob.2002.125740 Feibus, 2008, FDA's proposed rule for pregnancy and lactation labeling: Improving maternal child health through well‐informed medicine use, Journal of Medical Toxicology, 4, 284, 10.1007/BF03161214 Food and Drug Administration (FDA), 2008, Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling, Federal Register, 73, 30831 Food and Drug Administration (FDA), 2014 Food and Drug Administration (FDA), 2014 Hamilton, 2012, Births: Preliminary data for 2011, National Vital Statistics Reports, 61, 1 Lupattelli, 2014, Medication use in pregnancy: A cross‐sectional, multinational web‐based study, BMJ Open, 4, e004365, 10.1136/bmjopen-2013-004365 Mazer‐Amirshahi, 2014, Trends in pregnancy labeling and data quality for US‐approved pharmaceuticals, American Journal of Obstetrics & Gynecology, 211, 690e.1, 10.1016/j.ajog.2014.06.013 Ramoz, 2014, Recent changes in pregnancy and lactation labeling: Retirement of risk categories, Pharmacotherapy, 34, 389, 10.1002/phar.1385 Whitkop, 2009, New prescription drug labeling regulations and the demise of “the letter.”, Obstetrics & Gynecology, 114, 502, 10.1097/AOG.0b013e3181b5bacc